These compounds may interact with:
Estrogen receptor
Potentially involved in: acquired metabolic disease; heart disease; osteoporosis; breast cancer; kidney cancer; substance-related disorder; carcinoma; endometrial cancer; ductal carcinoma in situ; endometriosis; ovarian cancer; leiomyoma; prostate cancer; breast disease; lobular neoplasia; uterine fibroid; vascular disease; infertility; breast fibroadenoma; obesity
Disease data sourced from Pharos.